Peptide Therapy for Women: What the Clinical Evidence Actually Shows
A physician's evidence-based guide to peptide therapy for women — covering hormonal interactions, key peptides, dosing considerations, and who is a suitable candidate.
Peptide Therapy
Moderate EvidenceCJC-1295 / Ipamorelin
Growth hormone secretagogues stimulating pulsatile GH release through complementary pituitary pathways.
01
02
Peptides for Muscle Growth: What the Evidence Actually Supports
Evidence-based review of peptides for muscle growth. GH secretagogues, BPC-157 for recovery, safety risks, and what works based on clinical experience.
03
CJC-1295/Ipamorelin vs Tesamorelin: Growth Hormone Secretagogues Compared
A physician's comparison of CJC-1295/Ipamorelin and tesamorelin — mechanisms, evidence, body composition effects, and which GH secretagogue suits which patient.
04
CJC-1295/Ipamorelin Dosage: Growth Hormone Protocol
Evidence-based CJC-1295/Ipamorelin dosing guide by Dr. Julian Douwes. Nightly subcutaneous protocols, DAC vs no-DAC, cycling, and growth hormone optimization.
05
CJC-1295/Ipamorelin for Weight Loss and Body Composition
CJC-1295/Ipamorelin for fat loss and body recomposition. Dr. Julian Douwes explains growth hormone mechanisms, realistic timelines, and what the evidence supports.
06
CJC-1295/Ipamorelin: Growth Hormone Secretagogues
CJC-1295 and Ipamorelin review by Dr. Julian Douwes. Growth hormone optimization, body composition, evidence for GH secretagogues, dosing and safety.
